SCHEMBL10180606

SCHEMBL10180606

CCOCc1cc(Cl)cc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
TSHR P16473 3/20 0.55
MAPT P10636 5/20 0.36
MAPK1 P28482 2/20 0.35
GRIN2D O15399 5/20 0.35
GRIN3B O60391 5/20 0.35
GRIN1 Q05586 5/20 0.35
GRIN2A Q12879 5/20 0.35
GRIN2B Q13224 5/20 0.35
GRIN2C Q14957 5/20 0.35
GRIN3A Q8TCU5 5/20 0.35
POLB P06746 2/20 0.35
HPD P32754 2/20 0.34
S1PR4 O95977 4/20 0.33
LMNA P02545 4/20 0.33
NPC1 O15118 3/20 0.33
KMT2A Q03164 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10181382 0.88 TSHR (0.51) ALDH1A1TSHRMAPTMAPK1GRIN2D
SCHEMBL10181446 0.85 ALDH1A1 (0.49) ALDH1A1TSHRMAPTGRIN2DGRIN3B
SCHEMBL10179645 0.84 TSHR (0.58) ALDH1A1TSHRMAPTMAPK1GRIN2D
SCHEMBL10181559 0.80 TSHR (0.53) ALDH1A1TSHRMAPTMAPK1GRIN2D
SCHEMBL5131993 0.75 ALDH1A1 (0.64) ALDH1A1TSHRMAPTMAPK1GRIN2D
SCHEMBL10179648 0.75 ALDH1A1 (0.64) ALDH1A1TSHRMAPK1GRIN2DGRIN3B
SCHEMBL29005669 0.75 ALDH1A1 (0.48) ALDH1A1TSHRMAPTGRIN2DGRIN3B
SCHEMBL27928262 0.74 ALDH1A1 (0.33) ALDH1A1TSHRMAPTPOLBLMNA
SCHEMBL954217 0.73 ALDH1A1 (1.00) ALDH1A1TSHRMAPTMAPK1GRIN2D
SCHEMBL10180308 0.72 GRIN2D (0.35) ALDH1A1MAPTGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2474536-B1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL IND CO (JP) 2014-06-25 EP disclosed
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL INDUSTRY CO., LTD (JP) 2012-07-12 US disclosed
EP-2474536-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF Ihara Chemical Industry Co., Ltd. (JP) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF DPYD, UMPS, PNP ALDH1A1 238/4885TSHR 3409/4885MAPT 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.